Atea Pharmaceuticals shares owned by Gladius Capital Management
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Gladius Capital Management
from 13F filings
Historical chart of Gladius Capital Management investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by Gladius Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by Gladius Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $28k | 8.5k | 3.35 |
| 2024-06-30 | $29k | 8.8k | 3.31 |
| 2024-03-31 | $35k | 8.5k | 4.04 |
| 2023-09-30 | $26k | 8.6k | 3.00 |
| 2023-06-30 | $16k | 4.3k | 3.74 |
| 2023-03-31 | $26k | 7.7k | 3.35 |
| 2022-12-31 | $38k | 7.9k | 4.81 |
| 2022-09-30 | $28k | 4.8k | 5.77 |
More positions owned by Gladius Capital Management
View all positions for Gladius Capital Management